Identity and Contact Information of the Data Controller This privacy policy applies to all personal data processed by Sensilab d.o.o., with its registered office at Verovkova 55a, 1000 Ljubljana, Slovenia, , company registration number 2113732000, and Vision Healthcare Group, with its registered office at Grote Markt 41, 8500 Kortrijk, Belgium, company registration number BE 0685.849.188, acting as joint controllers under the GDPR (hereafter called 'Data Controller')
Personalized medicine: Advances in pharmacogenomics may allow for more targeted use of GLP-1s, optimizing efficacy and minimizing side effects based on individual genetic profiles
Riesgo angiognico hipottico en patologa neoplsica preexistente (sin evidencia documentada, pero plausible mecansticamente)
GLP-1 RAs have been shown to improve glycemic control and insulin resistance
Consume Responsibly: Not recommend for children, people sensitive to caffeine, pregnant women or women who are nursing